| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/30/2008 | CN100384876C Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographics |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/30/2008 | CA2610104A1 Characterizing prostate cancer |
| 04/30/2008 | CA2608924A1 Analytical test strip with electroluminescent module |
| 04/30/2008 | CA2608609A1 Analytical test strip with electroluminescent lamp |
| 04/30/2008 | CA2606589A1 Prostate cancer field effect analysis methods and kits |
| 04/29/2008 | US7366719 Method for the manipulation, storage, modeling, visualization and quantification of datasets |
| 04/29/2008 | US7366704 System and method for deconvoluting the effect of topography on scanning probe microscopy measurements |
| 04/29/2008 | US7366617 Mass determination for biopolymers |
| 04/29/2008 | US7366063 Optical discs for measuring analytes |
| 04/29/2008 | US7365239 Non-human transgenic animal models and cells; dermatitis, psoriasis, airway allergy, asthma, AIDS, an autoimmune disorder or graft rejection |
| 04/29/2008 | US7365181 Probes for chondrogenesis |
| 04/29/2008 | US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365096 Use of amine-substituted cyclododecanone compounds such as 1,3-bis(dimethylaminomethyl)cyclododecan-2-one; Immunosuppressants; transplant rejection, graft versus host disease; fewer side effects than with conventional immunosuppressants |
| 04/29/2008 | US7365050 Using calcium channel blockers |
| 04/29/2008 | US7364921 Method and apparatus for separating biological materials and other substances |
| 04/29/2008 | US7364920 nucleation centers are bound, deposited at one or more sites on a substrate, substrate is then contacted with a treatment formulation which comprises soluble gold-providing agent(AuI/SCN/2 or AuI/SCN/2, hydroquinone reducing agent) gold is deposited onto a nucleation center to yield gold metal deposits |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364918 Polydiacetylene; forming transducers |
| 04/29/2008 | US7364917 Apparatus and method for detecting vaporized gas |
| 04/29/2008 | US7364912 Controlling the flow of hydrogen and ammonia from a hydrogen generator during a breakthrough with hydrated copper (II) chloride trap |
| 04/29/2008 | US7364911 Methods for isolating and labeling sample molecules |
| 04/29/2008 | US7364908 charging a mixture of compounds to a non-fluorous solid phase (silica gel, alumina, zirconia) and eluting with a fluorous eluting fluid (hydrofluoroalkane, a hydrofluoroether, a hydrofluoroamine, a perfluoroalkane, a perfluoroether, or a perfluoroamine) and a cosolvent: difference in fluorous nature |
| 04/29/2008 | US7364907 Separating samples batches according to compound groups; high throughput assays; drug screening, design and development |
| 04/29/2008 | US7364906 Products and methods for single parameter and multiparameter phenotyping of cells |
| 04/29/2008 | US7364905 With live tissue or substitutes under controlled conditions during compound absorption and related processes |
| 04/29/2008 | US7364899 Appartus for use in monitoring migration of biopolymers |
| 04/29/2008 | US7364898 detection and quantification of different sets of target molecules, being possibly present simultaneously in a biological sample by the use of a microarray present upon a solid support surface containing different sets of capture molecules present in different location |
| 04/29/2008 | US7364897 Methods and devices for performing chemical reactions on a solid support |
| 04/29/2008 | US7364887 Osteoarthritis; rheumatic diseases; antiarthritic agents |
| 04/29/2008 | US7364871 screening for candidates that modulate interaction of MEKK and MIF1 comprising a) contacting MIF1 protein with MEKK protein and a candidate molecule, and b) detecting modulation of the interaction of MIF1 and MEKK; antagonists or agonists of MIF1/MSP58-MEKK1 binding |
| 04/29/2008 | US7364869 Method of detecting antigen-specific T lymphocytes |
| 04/29/2008 | US7364868 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders |
| 04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 04/29/2008 | US7364866 Insecticides; generating immunology response |
| 04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364863 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine |
| 04/29/2008 | US7364862 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/29/2008 | US7364860 Diagnosing hepatitis c infection using genetically engineered lymphadenopathy associated viral protein |
| 04/29/2008 | US7364859 Methods of using bioelastomers |
| 04/29/2008 | US7364852 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
| 04/29/2008 | US7364851 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication |
| 04/29/2008 | US7364850 DNA probe array |
| 04/29/2008 | US7364849 Treatment of substrates for immobilizing biomolecules |
| 04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364843 an that expresses a chromogenic enzyme; virus is a bacteriophage; enzyme is a peroxidase and alkaline phosphatase; chromogenic substrate is p-nitrophenylphosphate; target cell is a prokaryotic cell |
| 04/29/2008 | US7364744 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
| 04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364719 Vasoregulating compounds and methods of their use |
| 04/29/2008 | US7364701 Liquid homogenizing unit and high speed liquid chromatograph equipped with the same |
| 04/29/2008 | US7364700 Ozone gas sensing element, detection apparatus, and measurement method |
| 04/29/2008 | US7364699 Containers for reading and handling diagnostic reagents and methods of using the same |
| 04/29/2008 | US7364697 Apparatus comprising infrared camera for rapidly screening arrays of diverse materials on single substrate surfaces; combinatorial synthesis and characterization of libraries of diverse materials |
| 04/29/2008 | US7364103 Method and device for the alignment and location of a sample such as tablets, pills or tablettes |
| 04/29/2008 | US7363817 System and technique for detecting the presence of foreign material |
| 04/29/2008 | US7363800 Apparatus and method for measuring compositional parameters of a mixture |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2297368C In vitro evaluation of animal or human lens characteristics |
| 04/29/2008 | CA2285136C Coccidiosis vaccines |
| 04/29/2008 | CA2250485C Diagnostic agent for diabetes |
| 04/29/2008 | CA2230372C Quantitation of p97 to diagnose and monitor alzheimer's disease |
| 04/27/2008 | CA2586614A1 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 04/26/2008 | CA2607616A1 Methods and systems for ensuring the security of grain stores |
| 04/26/2008 | CA2563179A1 Quantification of microsphere suspension hybridization and uses thereof |
| 04/24/2008 | WO2008049083A2 Lateral flow and flow-through bioassay based on patterned porous media, methods of making same, and methods of using same |
| 04/24/2008 | WO2008049075A2 Electrochemical determination of analytes |
| 04/24/2008 | WO2008049034A1 System for assays of aminotranferase |
| 04/24/2008 | WO2008048795A2 Methods for determining collateral artery development in coronary artery disease |
| 04/24/2008 | WO2008048695A2 Synthesis and applications of nanomaterials derived from self-assembled diacetylenic triglycerides |
| 04/24/2008 | WO2008048680A2 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/24/2008 | WO2008048670A2 Compositions and methods for modulating tlr14 activity |
| 04/24/2008 | WO2008048616A2 Microfluidic magnetophoretic device and methods for using the same |
| 04/24/2008 | WO2008048570A2 Piwil2-related biomarkers and cell lines useful therewith |
| 04/24/2008 | WO2008048508A2 Prognostic biomarkers in patients with ovarian cancer |
| 04/24/2008 | WO2008048371A2 Methods and compositions for highly sensitive analysis of markers and detection of molecules |
| 04/24/2008 | WO2008048345A2 Detection systems for mass labels |
| 04/24/2008 | WO2008048322A1 Mouse models to study cachexia |
| 04/24/2008 | WO2008048300A2 Pathogen detection biosensor |
| 04/24/2008 | WO2008048231A2 Biosensor method and system based on feature vector extraction |
| 04/24/2008 | WO2008048222A2 Method and cmos-based device to analyze molecules and nanomaterials based on the electrical readout of specific binding events on functionalized electrodes |
| 04/24/2008 | WO2008048221A2 Nanostructures for polarized imaging and receptor/ligand quantization: breaking the diffraction limit for imaging |
| 04/24/2008 | WO2008048209A2 Functionalization of nanofluidic channels |
| 04/24/2008 | WO2008048141A1 Method for biologically monitoring the environment (variants)and a system for carrying out said method |
| 04/24/2008 | WO2008048101A1 Process for providing a plant with an identification label |
| 04/24/2008 | WO2008048097A1 Cross-spot |
| 04/24/2008 | WO2008048087A1 Method for identifying natural drug analogues |
| 04/24/2008 | WO2008047947A1 Method for determining effect of cisplatin administration and kit for determining effect of cisplatin administration |
| 04/24/2008 | WO2008047941A1 Method of immunoassaying urinary component and reagent to be used therefor |
| 04/24/2008 | WO2008047875A1 Microanalysis measuring apparatus and microanalysis measuring method using the same |